EUVIMEDEUVIMED entdecken
Crossref

Efficacy of anti-VEGF intravitreal injection in traumatic submacular hemorrhage: a retrospective study

Jiaming Wang, Liuhui Huang, Lifei Chen, Sheng Chen, Shenwen Liu

International Ophthalmology · 2024

DOI: 10.1007/s10792-024-03168-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Jiaming Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, 18th Zetian Road, Futian District, Shenzhen, 518040, China. Hauptthemen laut MEDLINE: Intravitreal Injections, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Visual Acuity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Committee, P.R. China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: In this study we investigated the efficacy of short-term intravitreal injections of anti-vascular endothelial growth factors (anti-VEGF) in treating traumatic submacular hemorrhage. METHODS: A total of 115 patients were diagnosed with submacular hemorrhage between 2018 and 2022 at Shenzhen Eye Hospital. In a retrospective analysis, we examined 13 of these patients who presented with submacular hemorrhage and choroidal rupture due to ocular trauma. Eight patients were treated with intravitreal anti-VEGF injection and 5 with oral drugs. We systematically analyzed changes in their ocular conditions pre and post-treatment. The evaluations encompassed best-corrected visual acuity (BCVA), optical coherence tomography, fundus fluorescein angiography, and retinal imaging. RESULTS: The 13 patients diagnosed with submacular hemorrhage comprised of 10 males and 3 female, with their age ranging between 27 and 64 years, with an average age of 38.1 years (standard deviation [SD]: 11.27). A statistically significant reduction in central foveal thickness (CFT) was observed following intravitreal injections of anti-VEGF drugs (P = 0.03). In control group, the CFT was reduced without statistical significance (P = 0.10). The BCVA of the patients in treatment group improved significantly from 1.15 (SD: 0.62. Range: 0.4-2) to 0.63 (SD: 0.59. Range: 0.1-1.6), indicating an average increase of 4.13 lines (SD: 3.36. Range: 0-9) as measured by the visual acuity test using an eye chart (P = 0.01). The difference between baseline visual acuity and final visual acuity was not statistically significant in control group (P = 0.51). CONCLUSION: Short-term administration of anti-VEGF drugs exhibited significant efficacy in reducing submacular hemorrhage following ocular trauma and enhancing visual acuity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intravitreal InjectionsAngiogenesis InhibitorsVascular Endothelial Growth Factor AVisual AcuityRetinal HemorrhageTomography, Optical CoherenceFluorescein AngiographyEye InjuriesHumansRetrospective StudiesMaleFemaleMiddle AgedAdultTreatment OutcomeBevacizumabRanibizumabFundus OculiFollow-Up Studies

Stichwörter der Autor:innen

Anti-VEGFIntravitreal injectionOcular traumaRetinaSubmacular hemorrhage

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ABevacizumabRanibizumab

Autor:innen und Institutionen

  • Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, 18th Zetian Road, Futian District, Shenzhen, 518040, China.
  • Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, 3002, Australia.
  • Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, VIC, 3010, Australia.
  • Department of Ophthalmology, Tenth People's Hospital Affiliated with Shanghai Tongji University School of Medicine, Shanghai, 200072, China.
  • Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, 18th Zetian Road, Futian District, Shenzhen, 518040, China. shengchen0606cs@126.com.
  • Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, 18th Zetian Road, Futian District, Shenzhen, 518040, China. liu_shenwenlsw@126.com.

Förderung

  • Shenzhen Science and Technology Innovation Committee, P.R. China

Zitieren

APA

Wang, J., Huang, L., Chen, L., Chen, S., & Liu, S. (2024). Efficacy of anti-VEGF intravitreal injection in traumatic submacular hemorrhage: a retrospective study. International Ophthalmology. https://doi.org/10.1007/s10792-024-03168-9

Vancouver

Wang J, Huang L, Chen L, Chen S, Liu S. Efficacy of anti-VEGF intravitreal injection in traumatic submacular hemorrhage: a retrospective study. International Ophthalmology. 2024. doi:10.1007/s10792-024-03168-9

BibTeX
@article{Wang2024,
  author = {Wang, Jiaming and Huang, Liuhui and Chen, Lifei and Chen, Sheng and Liu, Shenwen},
  title = {Efficacy of anti-VEGF intravitreal injection in traumatic submacular hemorrhage: a retrospective study},
  journal = {International Ophthalmology},
  year = {2024},
  doi = {10.1007/s10792-024-03168-9}
}
Kostenlos starten →